GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.000
-0.280 (-6.54%)
At close: Sep 5, 2025, 4:00 PM
4.010
+0.010 (0.25%)
After-hours: Sep 5, 2025, 7:59 PM EDT
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.39 billion as of September 5, 2025. Its market cap has decreased by -51.93% in one year.
Market Cap
1.39B
Enterprise Value
1.66B
1-Year Change
-51.93%
Ranking
Category
Stock Price
$4.00
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.39B, a decrease of -89.03%. That is a compound annual growth rate of -36.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 1.39B | -22.33% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
| Sep 23, 2020 | 12.67B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |